关注
Brad Fortunato
Brad Fortunato
Bioinformatician, BIDMC
在 bidmc.harvard.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Liquid biopsy epigenomic profiling for cancer subtyping
SC Baca, JH Seo, MP Davidsohn, B Fortunato, K Semaan, S Sotudian, ...
Nature medicine 29 (11), 2737-2741, 2023
392023
Epigenomic signatures of sarcomatoid differentiation to guide the treatment of renal cell carcinoma
T El Zarif, K Semaan, M Eid, JH Seo, S Garinet, MP Davidsohn, P Sahgal, ...
Cell Reports 43 (6), 2024
32024
Detecting Small Cell Transformation in Patients with Advanced EGFR Mutant Lung Adenocarcinoma through Epigenomic cfDNA Profiling
T El Zarif, CB Meador, X Qiu, JH Seo, MP Davidsohn, H Savignano, ...
Clinical Cancer Research 30 (17), 3798-3811, 2024
22024
Author Correction: Liquid biopsy epigenomic profiling for cancer subtyping
SC Baca, JH Seo, MP Davidsohn, B Fortunato, K Semaan, S Sotudian, ...
nature medicine 30 (3), 907-907, 2024
22024
First report of the Southern Gulf Coast Toad (Incilius valliceps Wiegmann), Common House Gecko (Hemidactylus frenatusDuméril and Bibron), Schmidt’s Black-Striped Snake …
JR Finnerty, KS Lord, T Barbasch, R Laman, L Hakam, R Perez, ...
Caribbean Herpetology 81, 1-14, 2021
22021
Decoding the epigenetics and chromatin loop dynamics of androgen receptor-mediated transcription
UB Altıntaş, JH Seo, C Giambartolomei, D Ozturan, BJ Fortunato, ...
Nature Communications 15 (1), 9494, 2024
12024
Decoding the Epigenetics and Chromatin Loop Dynamics of Androgen Receptor-Mediated Transcription
N Lack, UB Altintas, JH Seo, C Giambartolomei, D Ozturan, B Fortunato, ...
Research Square, 2024
12024
Abstract B035: Detection and monitoring of translocation renal cell carcinoma via epigenomic profiling of cell-free DNA
S Garinet, K Semaan, J Caniff, N Phillips, J Berchuck, J Li, K Lyons, ...
Clinical Cancer Research 30 (21_Supplement), B035-B035, 2024
2024
44 Liquid biopsy epigenomic profiling for the detection of sarcomatoid renal cell carcinoma
K Semaan, TE Zarif, M Eid, J Canniff, N Phillips, B Fortunato, H Savignano, ...
The Oncologist 29 (Supplement_1), S4-S5, 2024
2024
1714P Detection and monitoring of translocation renal cell carcinoma via epigenomic profiling of cell-free DNA
S Garinet, K Semaan, J Canniff, N Phillips, M Davidsohn, JE Berchuck, ...
Annals of Oncology 35, S1027-S1028, 2024
2024
43 Epigenomic profiling of translocation renal cell carcinoma via liquid biopsy
S Garinet, K Semaan, J Canniff, N Phillips, M Davidsohn, J Berchuck, J Li, ...
The Oncologist 29 (Suppl 1), S25, 2024
2024
Abstract PS06-07: Liquid biopsy determination of HER2 status in breast cancer: results from a novel epigenomic platform
H Parsons, S Baca, A D'Ippolito, HH Jeong, K Smith, P Tarantino, ...
Cancer Research 84 (9_Supplement), PS06-07-PS06-07, 2024
2024
Comprehensive epigenomic profiling from plasma to inform therapy selection: A proof-of-concept study in cancer
T Clark, JH Seo, A D'Ippolito, A Gorthi, J Beagan, J Guess, A Donahue, ...
Cancer Research 84 (6_Supplement), 963-963, 2024
2024
Detection of sarcomatoid renal cell carcinoma using plasma cell-free DNA methylation.
K Semaan, T El Zarif, JH Seo, M Eid, J Canniff, B Fortunato, H Savignano, ...
Journal of Clinical Oncology 42 (4_suppl), 449-449, 2024
2024
Detection of neuroendocrine prostate cancer through plasma-based epigenomic profiling.
M Eid, K Semaan, JH Seo, MP Davidsohn, B Fortunato, ...
Journal of Clinical Oncology 42 (4_suppl), 201-201, 2024
2024
Epigenomic signatures as circulating and predictive biomarkers in sarcomatoid renal cell carcinoma
T El Zarif, K Semaan, M Eid, JH Sep, SG Semaan, MP Davidsohn, ...
bioRxiv, 2023.11. 27.568827, 2023
2023
1206O Clinical subtyping of cancer from blood based on comprehensive epigenomic profiling
S Baca, JH Seo, JE Berchuck, T El Zarif, RM Saliby, K Semaan, ...
Annals of Oncology 34, S711, 2023
2023
Epigenomic profiling nominates master transcription factors (TFs) driving sarcomatoid differentiation (SD) of renal cell carcinoma (RCC)
T El Zarif, K Semaan, M Eid, B Fortunato, AH Nassar, S Abou Alaiwi, ...
The Oncologist 28 (Suppl 1), S8, 2023
2023
Epigenomic profiling nominates master transcription factors (TFs) driving sarcomatoid differentiation of renal cell carcinoma (RCC)
K Semaan, T El Zarif, M Eid, V Shah, B Fortunato, RM Saliby, AH Nassar, ...
CANCER RESEARCH 83 (16), 2023
2023
Abstract A029: Epigenomic profiling nominates master transcription factors (TFs) driving sarcomatoid differentiation of renal cell carcinoma (RCC)
K Semaan, TE Zarif, M Eid, V Shah, B Fortunato, RM Saliby, AH Nassar, ...
Cancer Research 83 (16_Supplement), A029-A029, 2023
2023
系统目前无法执行此操作,请稍后再试。
文章 1–20